Inspira Technologies OXY (IINN)
(Real Time Quote from BATS)
$1.10 USD
-0.02 (-1.79%)
Updated Aug 30, 2024 01:38 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Price, Consensus and EPS Surprise
IINN 1.10 -0.02(-1.79%)
Will IINN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IINN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for IINN
INSPIRA (IINN) CART Gets FDA Listing, to Enhance Healthcare
Inspira (IINN) Unveils Business Targets for 2024-25
IINN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Inspira Technologies' (IINN) ART100 Gets FDA 510(k) Grant
Inspira Technologies (IINN) Strives to Get AMAR Nod for ART100
Inspira Technologies (IINN) Releases Favorable Data on VORTX
Other News for IINN
Inspira? to Publish HYLA? Clinical Results in Fourth Quarter 2024
Inspira Set to Unveil HYLA™ Blood Sensor Results
Inspira Technologies announces FDA listing of medical cart
Inspira? Technologies Announces FDA Listing and Market Readiness of New Product
Inspira Technologies Financial Update Revealed